Fairchem Organics LimitedQ1 FY27 Results & Financial Update
Fairchem Organics Limited: Q1 FY27 standalone results and company financials – revenue ₹176.15 Cr, PAT ₹10.01 Cr. Explore reported YoY/QoQ movements, margins, business drivers and management commentary. This page does not provide a rating, target price or investment recommendation.
Quarter at a glanceCurrent reported figures.Change figures appear when a comparable reported period is available.
Find an answer
Ask this result
Chart · Market context
Fairchem Organics price & chart
Market priceLoading…
1Y return—Price return
Loading market chart…
TradingView Lightweight Charts™ · Copyright © 2025 TradingView, Inc.TradingView
Market chartPrice chart temporarily unavailableThe price chart could not be loaded right now. The reported financial results remain available above.
Spotted a factual error?Tell us the number, date or statement and we will re-check the underlying records and calculations.Report an error
Quarterly Results AnalysisExplore Fairchem Organics Q1 FY27 quarterly results and earnings: revenue, profit (PAT), EBITDA, margins, YoY and QoQ growth, order book or business updates where reported, financial performance and management commentary. Reported figures and Nivata calculations are shown separately; no buy, sell or hold recommendation is provided.
Quarter overview
Quarterly earnings analysis
Fairchem Organics reported standalone revenue from operations of INR 1,761 million (INR 176.15 crore) for the quarter ended June 30, 2026, marking a 34.4% year-on-year increase compared to INR 1,311 million in Q1 FY26.
The top-line expansion was driven by higher price realizations stemming from elevated raw material costs and reduced import volumes resulting from supply chain constraints.
Profitability improved substantially during the quarter, with profit after tax (PAT) rising to INR 100 million (INR 10.01 crore) compared to INR 12 million in the corresponding period of the previous year.
EBITDA surged by 242.1% year-on-year to INR 179 million, while EBITDA margin expanded by 616 basis points to reach 10.16% from 3.97% in Q1 FY26, supported by improved domestic market realizations.
PAT margin strengthened by 479 basis points to 5.68% compared to 0.92% in Q1 FY26, reflecting enhanced operational leverage and better realization spreads.
Basic and diluted earnings per share (not annualized) stood at INR 7.95 for Q1 FY27, compared to INR 4.28 for the full year FY26 and INR 16.88 for FY25.
Total expenses for the quarter increased by 25.8% year-on-year to INR 1,583 million, reflecting higher input costs while remaining below the rate of revenue growth.
Finance costs rose to INR 18 million in Q1 FY27 from INR 10 million in Q1 FY26, while depreciation remained flat at INR 27 million.
01 · Business model
What does Fairchem Organics do?
Fairchem Organics Limited operates in the specialty oleochemicals sector with a 30-year legacy, focusing on waste-to-wealth manufacturing processes that convert by-products of vegetable oil refining into high-value oleochemicals and nutraceuticals.
The company's primary raw materials include acid oil (approximately 1.25% by-product of soft oils) and deodorizer distillate (approximately 0.25% by-product of hard oils), sourced directly from edible oil refineries across India via pan-India procurement capabilities.
Manufacturing takes place at a state-of-the-art facility located in Sanand, Ahmedabad, featuring critical processing equipment and design elements sourced from Germany and Switzerland.
The product portfolio spans oleochemicals such as linoleic/soya fatty acid, palmitic acid, dimer acid, isostearic acid, monomer acid, glycerine, and distilled fatty acid, alongside nutraceutical products including tocopherols and sterols, serving high-growth industries like paints, inks, cosmetics, lubricants, and pharmaceuticals.
02 · Historical context
What shaped the business before this quarter
The company established its state-of-the-art R&D laboratory in 2018, spanning 386 square meters with specialized European equipment.
The company concluded a share buyback of INR 340 million in January 2026.
The company has maintained a near-zero factory accident record since inception, with a single major fire incident occurring in November 2012 resulting in no casualties or injuries.
03 · Financial snapshot
Current-quarter financial snapshot
| Metric | Q1 FY27 |
|---|---|
| Revenue from operations | ₹176.15 Cr |
| Total income | ₹176.49 Cr |
| Profit before tax | ₹13.64 Cr |
| Profit after tax | ₹10.01 Cr |
| EPS | ₹7.95 |
04 · Why it moved
Why the quarter looked the way it did
What drove revenue
Domestic sales benefited from lower import volumes into India caused by broader supply chain constraints.
What drove margins
EBITDA margin expanded to 10.16% in Q1 FY27 from 3.97% in Q1 FY26, driven by superior price realizations in the domestic market.
Energy savings achieved through detailed energy audits and the substitution of imported catalysts with domestically sourced catalysts contributed to operating efficiency.
05 · Demand, customers & order book
Where demand is coming from
Maintains entrenched relationships spanning over 15 years with key customers in high-growth industries including paints, printing inks, lubricants, and cosmetics.
Maintains long-standing relationships with over 100 edible oil refinery suppliers for more than 20 years, procuring waste by-products directly at factory gates on short payment cycles.
06 · Segments, products & geography
Which parts of the business are doing the work
Geography and market mix
The company exports isostearic acid to several countries and targets increasing its export share to 25% initially and eventually to 50% of total sales, aided by level-playing tariffs with the US and proposed FTAs with the UK and EU.
The vast majority of raw materials and finished goods for domestic sales are procured or sold within a radius of 500 kilometers from the Sanand manufacturing facility.
07 · Capacity, projects & execution
What is being built, commissioned or delivered
Capacity, production and utilisation
Raw material throughput capacity expansion has been successfully completed with minimal capital expenditure, funded primarily through internal accruals.
Process lines feature low switching costs, enabling the facility to expand and contract production volumes as required with strict quality controls resulting in near-zero rejections.
Projects, capex and execution
Capacity expansion projects have been undertaken primarily through internal accruals following a judicious strategy based on market demand-supply evaluations.
08 · Strategy & new businesses
How the company is trying to change its growth mix
Management is actively pursuing four key strategies: cost optimization, product upgradation, new product development, and geographical diversification.
Initiatives include low-titre linoleic acid for oilfield drilling, distilled dimer, fatty oil upgradation for heating, bypass fat production from palm fatty acid distillate (PFAD), and the proposed addition of a new raw material under oleochemicals to manufacture niche chemicals.
09 · Reported developments
What changed operationally
Q1 FY27 PAT rose sharply to INR 100 million from INR 12 million in Q1 FY26, accompanied by a 34.4% increase in revenue from operations.
10 · Pressure points & risks
What is not going smoothly
Management highlighted ongoing macroeconomic uncertainties driven by geopolitical tensions in the Middle East affecting international trade flows.
11 · Items worth noticing
The line items that can distort a quick read
Exceptional items for Q1 FY27 were reported at nil (INR 0 million net of tax for the New Labour code).
12 · Cash flow & balance sheet
Profit is one thing. Cash and funding tell another part of the story.
Historical annual cash conversion cycle stood at 128 days in FY26, compared to 99 days in FY25 and 76 days in FY24.
Capital allocation & funding
Net debt to equity was 0.32x at the end of FY26, compared to 0.20x in FY25 and 0.02x in FY24, adhering to a governance policy of maintaining adequate capitalization and avoiding overleveraging.
13 · Management guidance & targets
What management is targeting from here
Management expressed conscious optimism for the year, noting that despite macroeconomic uncertainties stemming from the Middle East crisis, lower tariffs in the US, proposed FTAs with the UK and EU, and recent rupee devaluation are expected to improve capacity utilization.
14 · Beyond the numbers
What changed beyond the numbers
Reported update
ESG and governance framework
The company adheres to Zero Liquid Discharge practices via multi-effect evaporators and agitated thin film dryers, maintains ISO 9001, ISO 14001, and ISO 45001 certifications, and undergoes statutory audits by KPMG, with financial statements audited by a Big Four firm for the past nine years.
15 · Key Q&A
The quarter, answered directly
What does Fairchem Organics do?
Fairchem Organics Limited operates in the specialty oleochemicals sector with a 30-year legacy, focusing on waste-to-wealth manufacturing processes that convert by-products of vegetable oil refining into high-value oleochemicals and nutraceuticals.
What is the clearest takeaway from Q1 FY27?
Fairchem Organics reported standalone revenue from operations of INR 1,761 million (INR 176.15 crore) for the quarter ended June 30, 2026, marking a 34.4% year-on-year increase compared to INR 1,311 million in Q1 FY26.
What drove revenue or demand?
Domestic sales benefited from lower import volumes into India caused by broader supply chain constraints.
What mattered most for margins or profitability?
EBITDA margin expanded to 10.16% in Q1 FY27 from 3.97% in Q1 FY26, driven by superior price realizations in the domestic market.
What changed operationally beyond the headline numbers?
Raw material throughput capacity expansion has been successfully completed with minimal capital expenditure, funded primarily through internal accruals.
What is management guiding or targeting from here?
Management expressed conscious optimism for the year, noting that despite macroeconomic uncertainties stemming from the Middle East crisis, lower tariffs in the US, proposed FTAs with the UK and EU, and recent rupee devaluation are expected to improve capacity utilization.
16 · Scenario calculator
Earnings sensitivity: what if growth and margins change?
Starting point
Build your own next-quarter scenario
Reported values are prefilled where a comparable basis is available. Otherwise, the field starts at 0. You can overwrite every field.
Example: enter 10 for 10% revenue growth. Enter -100 for a 1 percentage-point margin decline.
Scenario output
Scenario revenue / income₹0 cr
Scenario profit after tax₹0 cr
Profit change vs base₹0 cr (0%)
Scenario margin0%
Growth needed to keep profit flat after this margin move0%
The calculator holds the selected margin basis constant except for the basis-point adjustment you enter. It does not estimate tax, finance cost, dilution, working capital, valuation or share price.
17 · Next filing checkpoints
What the next disclosure can confirm or change
- 01
Capacity utilization trajectory: Track capacity utilization rates throughout FY27 against management expectations of improvement driven by export opportunities and tariff adjustments.
- 02
Export share expansion: Monitor progress toward the stated target of increasing export share from current levels to 25% initially and 50% over the longer term.
Learn the metrics
Need the concepts first?
Use Nivata’s plain-English guides to understand the accounting terms used in this brief before interpreting them.